https://www.optimumcomms.com/wp-content/uploads/2023/02/StormTx_Logo_300-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2022/08/Optimum_Logo_Build.svg
Healthcare Team2023-12-08 16:43:002023-12-08 16:43:00STORM Therapeutics’ First-in-Class tRNA methyltransferase inhibitor of METTL1 to be Presented at the 65th Annual ASH Conference
https://www.optimumcomms.com/wp-content/uploads/2023/02/Ionctura_Logo_300px-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2022/08/Optimum_Logo_Build.svg
Healthcare Team2023-12-08 08:39:132023-12-08 08:39:13Updated clinical safety and efficacy data for iOnctura’s roginolisib presented at ESMO Immuno-Oncology Congress 2023
https://www.optimumcomms.com/wp-content/uploads/2023/12/Vesper_Bio_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2022/08/Optimum_Logo_Build.svg
Healthcare Team2023-12-07 09:08:022023-12-07 12:36:37Vesper Bio doses first volunteer in Phase I study of first-in-class oral treatment for Frontotemporal Dementia (FTD)
https://www.optimumcomms.com/wp-content/uploads/2023/06/Synaffix_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2022/08/Optimum_Logo_Build.svg
Healthcare Team2023-12-07 08:49:562023-12-07 08:49:56Innovent Biologics and Synaffix Expand ADC Collaboration Following Positive Preliminary Clinical Signal from Ongoing Phase 1 Study
https://www.optimumcomms.com/wp-content/uploads/2023/02/Ariceum_Logo_300x180px-2.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2022/08/Optimum_Logo_Build.svg
Healthcare Team2023-12-06 08:48:112023-12-06 08:48:11Ariceum Therapeutics announces granting of US and Canadian patents for its Gallium-68 radiopharmaceutical production kit
https://www.optimumcomms.com/wp-content/uploads/2023/06/Versameb_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2022/08/Optimum_Logo_Build.svg
Healthcare Team2023-12-05 13:34:152023-12-05 13:34:15Versameb AG Names Dr. Alexandre LeBeaut as Chair of the Board of Directors
https://www.optimumcomms.com/wp-content/uploads/2023/02/Sofinnova_Logo_300-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2022/08/Optimum_Logo_Build.svg
Healthcare Team2023-12-05 09:34:492023-12-05 13:36:12Sofinnova Partners unveils Sofinnova.AI: A cutting-edge artificial intelligence platform set to transform its life sciences investment practice
https://www.optimumcomms.com/wp-content/uploads/2023/12/Kling_Bio_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2022/08/Optimum_Logo_Build.svg
Healthcare Team2023-12-05 09:18:222023-12-05 09:31:52Kling Bio Announces Appointment of Dr Stefano Gullà as Chief Scientific Officer
https://www.optimumcomms.com/wp-content/uploads/2023/10/Mission_Therapeutics_Logo_300x180px-80x80Web_Logos-1.png
180
300
Marketing Team
https://www.optimumcomms.com/wp-content/uploads/2022/08/Optimum_Logo_Build.svg
Marketing Team2023-12-05 08:55:092023-12-05 08:56:47Mission Therapeutics granted MHRA Clinical Trial Authorisation (CTA) for MTX325 for the treatment of Parkinson’s Disease
https://www.optimumcomms.com/wp-content/uploads/2023/08/Bioinnovation_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2022/08/Optimum_Logo_Build.svg
Healthcare Team2023-11-30 16:18:582023-11-30 16:19:27The first six companies enter the Deep Tech Lab – Quantum start-up accelerator at BII to unlock the potential in quantum science
https://www.optimumcomms.com/wp-content/uploads/2023/06/Poolbeg_Logo_300x180px-80x80-4.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2022/08/Optimum_Logo_Build.svg
Healthcare Team2023-11-30 09:07:212023-11-30 09:07:21Poolbeg Pharma plc – Directorate Change
https://www.optimumcomms.com/wp-content/uploads/2023/08/Astraveus.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2022/08/Optimum_Logo_Build.svg
Healthcare Team2023-11-28 10:16:212023-11-28 10:56:19Highly experienced CDMO expert Michel Spagnol appointed Chairman of Astraveus
https://www.optimumcomms.com/wp-content/uploads/2023/02/ViCentra_Logo_300x180px-3.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2022/08/Optimum_Logo_Build.svg
Healthcare Team2023-11-21 10:16:212023-11-21 14:16:02Kaleido launches cutting-edge Hybrid Closed Loop system with Diabeloop and Dexcom for people with diabetes
https://www.optimumcomms.com/wp-content/uploads/2023/06/Poolbeg_Logo_300x180px-80x80-4.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2022/08/Optimum_Logo_Build.svg
Healthcare Team2023-11-21 09:43:012023-11-21 14:19:24Poolbeg Pharma – Immunomodulator II patent granted in Japan
https://www.optimumcomms.com/wp-content/uploads/2023/02/Biocomposites_Logo_300px-2.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2022/08/Optimum_Logo_Build.svg
Healthcare Team2023-11-21 08:51:552023-11-21 08:51:55Biocomposites expands its product portfolio with the launch of SYNICEM™ spacers in the UK
https://www.optimumcomms.com/wp-content/uploads/2023/06/Poolbeg_Logo_300x180px-80x80-4.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2022/08/Optimum_Logo_Build.svg
Healthcare Team2023-11-16 10:08:222023-11-16 10:08:22Poolbeg Pharma – POLB 001 LPS Challenge Trial Data to be Presented at IUIS
https://www.optimumcomms.com/wp-content/uploads/2023/06/Versameb_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2022/08/Optimum_Logo_Build.svg
Healthcare Team2023-11-16 09:21:472023-11-16 09:21:47Versameb Announces FDA Clearance of IND Application for VMB-100 in the Treatment of Stress Urinary Incontinence
https://www.optimumcomms.com/wp-content/uploads/2023/11/IO-Biotech.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2022/08/Optimum_Logo_Build.svg
Healthcare Team2023-11-13 13:22:592023-11-16 09:22:20IO Biotech Announces 2023 Third Quarter Results
https://www.optimumcomms.com/wp-content/uploads/2023/11/IO-Biotech.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2022/08/Optimum_Logo_Build.svg
Healthcare Team2023-11-13 13:12:492023-11-13 13:22:21IO Biotech Appoints Helen Collins, MD, to its Board of Directors
https://www.optimumcomms.com/wp-content/uploads/2023/10/Mission_Therapeutics_Logo_300x180px-80x80Web_Logos-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2022/08/Optimum_Logo_Build.svg
Healthcare Team2023-11-13 10:09:242023-11-13 12:08:33Mission Therapeutics announces publication in Nature Communications outlining potential of experimental drug MTX325 as a disease-modifying therapy for Parkinson’s DiseaseFor more information about Optimum Strategic Communications, please get in touch.
